2014 - 2014Analysis and examination of current product lines and market evaluation for improved client orientation and reduction of future development costs.
Novartis
- Master Student
RUEIL MALMAISON 2013 - 2013Internship, Novartis Institute of Biomedical Research, NIBR
· Department of Oncology, Lab of Eric Billy. shRNA cloning and validation for in-vitro and in-vivo screening
· Establishing and optimizing the basic conditions for high-throughput in-vivo pooled shRNA screens in primary human sarcoma xenograft cells and validation of gene-specific shRNA constructs.
· Techniques used: cell culture, virus production, vector cloning, infection of human cells, qRT-PCR, western blot
BIOSS Freiburg, Center for Biological Signaling Studies
- Internship
2012 - 2012· Synthetic biology option in the lab of Prof. Dr. Wilfried Weber
· Marketing project: Finding the best application for a patented externally controlled drug depot, definition of its therapeutic indication and market analysis
· Lab project: development of a hydrogel drug depot responsive to quercetine
· Techniques used: design and planning of cloning strategies, fusion-/colony-PCR, protein production and purification, size-exclusion chromatography
University Freiburg, Departement de
- Internship
2011 - 2011· Department for Molecular Embryology: adrenal gland development in mice embryos
· Techniques used: genotyping, cryo-slicing, in-situ hybridization
Strasbourg2010 - 2013Diplôme d'Ingénieur en Biotechnologie
Tri-national Engineering School for Biotechnology (France, Germany, Switzerland)
Final grade: 13.46 (out of a scale from 1 - 20, with 20 being the best)
Albert-Ludwigs-University Freiburg (Freiburg)
Freiburg2007 - 2010Vordiplom
Equivalent to an Intermediate Examination
Final grade: 2.8 (out of a scale from 1 - 6, with 1 being the best)
